Australia · Delayed Price · Currency is AUD Cynata Therapeutics Statistics
Total Valuation
ASX:CYP has a market cap or net worth of AUD 2.68 million. The enterprise value is 1.78 million.
| Market Cap | 2.68M |
| Enterprise Value | 1.78M |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CYP has 243.45 million shares outstanding. The number of shares has increased by 15.49% in one year.
| Current Share Class | 243.45M |
| Shares Outstanding | 243.45M |
| Shares Change (YoY) | +15.49% |
| Shares Change (QoQ) | +2.70% |
| Owned by Insiders (%) | 15.15% |
| Owned by Institutions (%) | 6.38% |
| Float | 195.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | -6.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -325.34% and return on invested capital (ROIC) is -174.84%.
| Return on Equity (ROE) | -325.34% |
| Return on Assets (ROA) | -114.22% |
| Return on Invested Capital (ROIC) | -174.84% |
| Return on Capital Employed (ROCE) | 1,982.33% |
| Weighted Average Cost of Capital (WACC) | 10.23% |
| Revenue Per Employee | 855,809 |
| Profits Per Employee | -4.54M |
| Employee Count | 2 |
| Asset Turnover | 0.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.21% in the last 52 weeks. The beta is 1.09, so ASX:CYP's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -94.21% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 25.49 |
| Average Volume (20 Days) | 413,840 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CYP had revenue of AUD 1.71 million and -9.09 million in losses. Loss per share was -0.04.
| Revenue | 1.71M |
| Gross Profit | 1.71M |
| Operating Income | -7.82M |
| Pretax Income | -9.09M |
| Net Income | -9.09M |
| EBITDA | -7.55M |
| EBIT | -7.82M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 897,418 in cash and no debt, with a net cash position of 897,418 or 0.00 per share.
| Cash & Cash Equivalents | 897,418 |
| Total Debt | n/a |
| Net Cash | 897,418 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -394,240 |
| Book Value Per Share | -0.00 |
| Working Capital | -629,205 |
Cash Flow
| Operating Cash Flow | -6.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 260,313 |
| Net Borrowing | n/a |
| Free Cash Flow | -6.74M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -456.59% |
| Pretax Margin | -531.03% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:CYP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.49% |
| Shareholder Yield | -15.49% |
| Earnings Yield | -339.41% |
| FCF Yield | -251.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 2013. It was a reverse split with a ratio of 0.05.
| Last Split Date | Oct 31, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ASX:CYP has an Altman Z-Score of -101.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -101.24 |
| Piotroski F-Score | 2 |